Lumos Pharma raises $14 mln in Series A funding
Lumos Pharma, an early stage biopharmaceutical company, has raised $14 million in Series A funding. The round was co-led by Sante Ventures and New Enterprise Associates.
5 February 2014•4 mins read
Lumos Pharma, an early stage biopharmaceutical company, has raised $14 million in Series A funding. The round was co-led by Sante Ventures and New Enterprise Associates.
